TENX Valuation

Tenax Therapeutics Inc

Add to Watchlist

Advanced Chart

6.000

-0.04(-0.662%)1D

Overview
Forecast
Valuation
Earnings

TENX Relative Valuation

TENX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TENX is overvalued; if below, it's undervalued.

Historical Valuation

Tenax Therapeutics Inc (TENX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.70. The fair price of Tenax Therapeutics Inc (TENX) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：6.04

Fair

-1.68

Trailing

Forward

0.00

EV/EBITDA

Tenax Therapeutics Inc. (TENX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.03. The thresholds are as follows: Strongly Undervalued below -0.48, Undervalued between -0.48 and -0.23, Fairly Valued between 0.29 and -0.23, Overvalued between 0.29 and 0.54, and Strongly Overvalued above 0.54. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-2.55

EV/EBIT

Tenax Therapeutics Inc. (TENX) has a current EV/EBIT of -2.55. The 5-year average EV/EBIT is -1.30. The thresholds are as follows: Strongly Undervalued below -9.70, Undervalued between -9.70 and -5.50, Fairly Valued between 2.90 and -5.50, Overvalued between 2.90 and 7.10, and Strongly Overvalued above 7.10. The current Forward EV/EBIT of -2.55 falls within the Historic Trend Line -Fairly Valued range.

0.00

Tenax Therapeutics Inc. (TENX) has a current PS of 0.00. The 5-year average PS is 0.44. The thresholds are as follows: Strongly Undervalued below -2.13, Undervalued between -2.13 and -0.84, Fairly Valued between 1.73 and -0.84, Overvalued between 1.73 and 3.01, and Strongly Overvalued above 3.01. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Tenax Therapeutics Inc. (TENX) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.25. The thresholds are as follows: Strongly Undervalued below -1.70, Undervalued between -1.70 and -0.72, Fairly Valued between 1.23 and -0.72, Overvalued between 1.23 and 2.21, and Strongly Overvalued above 2.21. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Tenax Therapeutics Inc. (TENX) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.23. The thresholds are as follows: Strongly Undervalued below -1.85, Undervalued between -1.85 and -0.81, Fairly Valued between 1.27 and -0.81, Overvalued between 1.27 and 2.31, and Strongly Overvalued above 2.31. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Tenax Therapeutics Inc (TENX) has a current Price-to-Book (P/B) ratio of 0.24. Compared to its 3-year average P/B ratio of 0.88 , the current P/B ratio is approximately -72.84% higher. Relative to its 5-year average P/B ratio of 2.95, the current P/B ratio is about -91.87% higher. Tenax Therapeutics Inc (TENX) has a Forward Free Cash Flow (FCF) yield of approximately -8.22%. Compared to its 3-year average FCF yield of -119.97%, the current FCF yield is approximately -93.15% lower. Relative to its 5-year average FCF yield of -91.55% , the current FCF yield is about -91.02% lower.

0.24

P/B

Median3y

0.88

Median5y

2.95

-8.27

FCF Yield

Median3y

-119.97

Median5y

-91.55

Competitors Valuation Multiple

The average P/S ratio for TENX's competitors is 21.69, providing a benchmark for relative valuation. Tenax Therapeutics Inc Corp (TENX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TENX.O

Tenax Therapeutics Inc

Rein Therapeutics Inc

Cuprina Holdings (Cayman) Ltd

Neurosense Therapeutics Ltd

108.13

29.38M

Performance Decomposition

Market capitalization of TENX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of TENX in the past 1 year is driven by Unknown.